{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:12:29Z","timestamp":1790190749640,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K23NS085049"],"award-info":[{"award-number":["K23NS085049"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003157","name":"Myasthenia Gravis Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003157","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2017.00034","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T22:46:16Z","timestamp":1486680376000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease Severity"],"prefix":"10.3389","volume":"8","author":[{"given":"John S.","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice M.","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vern","family":"Juel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Hobson-Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karissa","family":"Gable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti M.","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Balderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent J.","family":"Weinhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Guptill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"B2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.clim.2008.03.509","article-title":"Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis","volume":"128","author":"Sheng","year":"2008","journal-title":"Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low\/-) T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaut.2013.12.005","article-title":"Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis","volume":"52","author":"Yi","year":"2014","journal-title":"J Autoimmun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1084\/jem.186.10.1749","article-title":"Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice","volume":"186","author":"Mizoguchi","year":"1997","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1084\/jem.20021293","article-title":"Prevention of arthritis by interleukin 10-producing B cells","volume":"197","author":"Mauri","year":"2003","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1172\/JCI36030","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.4049\/jimmunol.0902385","article-title":"Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity","volume":"184","author":"Watanabe","year":"2010","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1186\/ar3736","article-title":"Interleukin-10 produced by B cells is crucial for the suppression of Th17\/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis","volume":"14","author":"Carter","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1182\/blood-2012-11-465658","article-title":"Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease","volume":"121","author":"Le Huu","year":"2013","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","article-title":"Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis","volume":"178","author":"Duddy","year":"2007","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1172\/JCI39933","article-title":"Identification of a B cell signature associated with renal transplant tolerance in humans","volume":"120","author":"Newell","year":"2010","journal-title":"J Clin Invest"},{"key":"B16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ki.2010.162","article-title":"Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype","volume":"78","author":"Pallier","year":"2010","journal-title":"Kidney Int"},{"key":"B17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/mus.23951","article-title":"Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis","volume":"49","author":"Sun","year":"2014","journal-title":"Muscle Nerve"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1212\/NXI.0000000000000077","article-title":"Characterization of B cells in muscle-specific kinase antibody myasthenia gravis","volume":"2","author":"Guptill","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jneuroim.2016.05.004","article-title":"Impaired regulatory B cells in myasthenia gravis","volume":"297","author":"Sheng","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.humimm.2015.09.006","article-title":"Regulatory B cell: new member of immunosuppressive cell club","volume":"76","author":"Ding","year":"2015","journal-title":"Hum Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/intimm\/dxv046","article-title":"Regulatory B10 cell development and function","volume":"27","author":"Lykken","year":"2015","journal-title":"Int Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1196\/annals.1254.057","article-title":"A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score","volume":"998","author":"Sanders","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature11501","article-title":"Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions","volume":"491","author":"Yoshizaki","year":"2012","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.4049\/jimmunol.1303397","article-title":"CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis","volume":"193","author":"Sheng","year":"2014","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1126\/science.1175194","article-title":"A vital role for interleukin-21 in the control of a chronic viral infection","volume":"324","author":"Yi","year":"2009","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4049\/jimmunol.0901967","article-title":"Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study","volume":"184","author":"Iannello","year":"2010","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.4049\/jimmunol.1001032","article-title":"IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection","volume":"185","author":"Yi","year":"2010","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1128\/JVI.02030-10","article-title":"HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function","volume":"85","author":"Chevalier","year":"2011","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrd4296","article-title":"Interleukin-21: a double-edged sword with therapeutic potential","volume":"13","author":"Spolski","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nm.1995","article-title":"Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis","volume":"15","author":"Caruso","year":"2009","journal-title":"Nat Med"},{"key":"B35","first-page":"172","article-title":"Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells","volume":"31","author":"Nakou","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cmi.2014.58","article-title":"IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation","volume":"12","author":"Deng","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0151761","DOI":"10.1371\/journal.pone.0151761","article-title":"IL-10-producing regulatory B cells are decreased in patients with common variable immunodeficiency","volume":"11","author":"Barsotti","year":"2016","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1182\/blood-2008-02-140087","article-title":"Induction of CD4+ T-cell anergy and apoptosis by activated human B cells","volume":"112","author":"Tretter","year":"2008","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.autrev.2011.11.018","article-title":"Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells","volume":"11","author":"Kessel","year":"2012","journal-title":"Autoimmun Rev"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00034\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T22:46:19Z","timestamp":1486680379000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00034\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":39,"URL":"https:\/\/doi.org\/10.3389\/fneur.2017.00034","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,10]]}}}